VivoSeq
Other

Invasive Procedure

0

Pipeline Programs↗

2

Active Trials↗

2

Companies Involved↗

Invasive Procedure is an early-stage landscape with 0 programs across 2 companies. The most active players are SFJ Pharmaceuticals, Inc., Octapharma.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

50/100

Attrition Rate

33/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

SFJ Pharmaceuticals, Inc.

0 programs

PreclinicalOctapharma logo

Octapharma

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

9

clinical trials

Completed3 · 33%
Withdrawn2 · 22%
Unknown status1 · 11%
Recruiting1 · 11%
Terminated1 · 11%
Not yet recruiting1 · 11%

Clinical Trials

Trial Activity

9 trials

Impact of Virtual Reality in Hematology and Oncology During Invasive Procedures in Children, Adolescents and Young Adults, from 7 to Less Than 25 Years Old
Recruiting·PPoitiers University Hospital·N/A·NCT05275881·60 enrolled
Relational Regulation: A Relational Approach to Music Therapy-based Procedural Support for Paediatric Patients and Families Facing Repeated Invasive Procedures
Not yet recruiting·Anglia Ruskin University·Preclinical·NCT07680348·20 enrolled
Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure
Completed·SSFJ Pharmaceuticals, Inc.·Phase 3·NCT04286438·226 enrolled
Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures
Completed·Octapharma logoOctapharma·Phase 3·NCT00618098·200 enrolled
Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures
Completed·RRutgers, The State University of New Jersey·Phase 3·NCT02637427·57 enrolled
Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
Terminated·FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·Phase 3·NCT00484822·206 enrolled
Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures.
Withdrawn·CCristália Produtos Químicos Farmacêuticos Ltda.·Phase 2/3·NCT01326078
Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants
Withdrawn·UUniversity Hospital, Angers·Phase 4·NCT02969746
Transfusion of Plasma Prior to Invasive Procedures Pilot Trial (TOPPIT)
Unknown status·OOttawa Hospital Research Institute·Phase 3·NCT02561026·80 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)